PuSH - Publikationsserver des Helmholtz Zentrums München: Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Gancheva, S.* ; Koliaki, C.* ; Bierwagen, A.* ; Nowotny, P.* ; Heni, M. ; Fritsche, A. ; Häring, H.-U. ; Szendrödi, J.* ; Roden, M.*

Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans.

Diabetes 64, 1966-1975 (2015)

Postprint

DOI

PMC

	Open Access Green

Abstract
Metriken
Zusatzinfos

Studies in rodents suggest that insulin controls hepatic glucose metabolism through brain-liver crosstalk, but human studies using intranasal insulin to mimic central insulin delivery provided conflicting results. In this randomized controlled cross-over trial we investigated effects of intranasal insulin on hepatic insulin sensitivity and energy metabolism in 10 patients with type 2 diabetes and 10 lean healthy participants (CON). Endogenous glucose production (EGP) was monitored with [6,6-(2)H2]glucose, hepatocellular lipids (HCL), adenosine triphosphate (ATP) and inorganic phosphate concentrations with (31)P/(1)H magnetic resonance spectroscopy. Intranasal insulin transiently increased serum insulin, followed by gradual lowering of blood glucose in CON only. Fasting hepatic insulin sensitivity index (HIS) was not affected by intranasal insulin in CON and patients. Only in CON, HCL decreased by 35%, whereas absolute hepatic ATP concentrations increased by 18% after three hours. A subgroup of CON received intravenous insulin to mimic the changes in serum insulin and blood glucose levels observed after intranasal insulin. This resulted in a 34% increase in HCL, without altering hepatic ATP concentrations. In conclusion, intranasal insulin does not affect HIS but rapidly improves hepatic energy metabolism in healthy humans, which is independent of peripheral insulinemia. These effects are blunted in patients with type 2 diabetes.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

8.095

2.027